CLINICAL_TRIALS
other
· 2025-07-28
Clinical Trial Update: NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus [NA]
Summary
Clinical trial update showing that NK510 Cell Therapy for refractory systemic lupus erythematosus is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Base Therapeutics (Shanghai) Co., Ltd. | Conditions: Refractory Systemic Lupus Erythematosus | NA | Status: NOT_YET_RECRUITING